Featured News
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
Virginia Workforce Award to AMPEL BioSolutions
AMPEL on Bloomberg Markets
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Local company unveils blood test to find treatments for chronic pain
Local company unveils blood test to find treatments for chronic pain
AMPEL BioSolutions Enters MDx Market With Lupus, Dermatology Gene Expression Assays
Innovator-of-Year to AMPEL
Reuters – Google Webinar Featuring AMPEL for Pharma Partnering
Reuters Events webinar with AMPEL, Google Cloud, Novartis, Asklepios and Pfizer to learn how data-driven innovation is reshaping clinical trials and paving the way towards faster drug discovery, more diverse patient enrolment and improved patient retention.
AMPEL’s AL/ML in Clinical Trial Design
Panel Presentation at the Precision Medical World Conference, June 29, 2022
Podcast on Lupus Diagnosis & Treatment
An Interview with Dr. Amrie Grammer on Dartmouth's "No Scrubs" Podcast